10-Q: Mannatech Q3 2025: Sales Decline, Net Income Rebounds

Mannatech reports an 8.1% Q3 2025 net sales decrease to $29.2 million, but achieves a net income of $1.9 million, reversing a prior-year loss.

Summary

• Net sales for the three months ended September 30, 2025, decreased by $2.6 million (8.1%) to $29.2 million compared to $31.7 million in the same period of 2024.
• Net sales for the nine months ended September 30, 2025, decreased by $7.5 million (8.4%) to $81.4 million compared to $88.9 million in the same period of 2024.
• Net income for the three months ended September 30, 2025, was $1.9 million ($1.01 per diluted share), a significant improvement from a net loss of $0.3 million ($0.17 per diluted share) in the prior-year quarter.
• Net loss for the nine months ended September 30, 2025, was $3.9 million ($2.06 per diluted share), compared to net income of $0.2 million ($0.12 per diluted share) in the same period of 2024.
• Cash and cash equivalents decreased by $4.3 million (37.3%) to $7.1 million as of September 30, 2025, from $11.4 million at December 31, 2024.
• Working capital decreased from $5.2 million at December 31, 2024, to $2.6 million at September 30, 2025.
• Operating activities used $2.7 million cash for the nine months ended September 30, 2025, a shift from providing $2.5 million in the same period of 2024.
• The company extended the maturity date of $3.6 million in unsecured notes payable to related parties from September 30, 2026, to March 31, 2027.

Sentiment

Score: 3

Explanation: While Q3 showed a net income rebound, the overall nine-month performance reflects significant declines in sales, a net loss, reduced cash, and negative cash flow from operations. The extension of related-party debt maturity and declining associate recruitment are concerning, indicating underlying business challenges despite some cost control efforts.

Positives

• Net income of $1.9 million for the three months ended September 30, 2025, reversing a net loss of $0.3 million in the prior-year quarter.
• Income from operations increased by $1.12 million (126.3%) to $2.007 million in the three months ended September 30, 2025, compared to $0.887 million in the same period of 2024.
• Gross profit as a percentage of net sales increased to 76.4% in the three months ended September 30, 2025, from 74.5% in the prior-year quarter, primarily due to higher sales prices and lower inventory reserve additions.
• Net realized and unrealized foreign currency gains of $0.6 million in the three months ended September 30, 2025, compared to a $1.5 million loss in the prior-year quarter.
• Selling and administrative expenses decreased by $0.7 million (7.8%) in the three months ended September 30, 2025, driven by reductions in payroll costs, travel and entertainment, warehouse costs, and charitable contributions.
• Sales for the third quarter of 2025 were higher than the first two quarters of 2025, indicating some sequential improvement.

Negatives

• Consolidated net sales decreased by 8.1% in the three months ended September 30, 2025, and 8.4% for the nine months ended September 30, 2025, primarily due to slowing demand in certain regions.
• Net loss of $3.9 million for the nine months ended September 30, 2025, compared to net income of $0.2 million in the prior-year period.
• Cash and cash equivalents decreased by 37.3% ($4.3 million) from $11.4 million at December 31, 2024, to $7.1 million at September 30, 2025.
• Working capital decreased by $2.6 million from $5.2 million at December 31, 2024, to $2.6 million at September 30, 2025.
• Operating activities used $2.7 million cash for the nine months ended September 30, 2025, a significant shift from providing $2.5 million in the prior-year period.
• Recruitment of new independent associates and preferred customers decreased by 21.9% to 13,078 in the third quarter of 2025.
• The number of active independent associates and preferred customers decreased by 13.0% in the Americas (Q3), 16.3% in Asia/Pacific (Q3), and 1.7% in EMEA (Q3).
• Revenue per active independent associate and preferred customer decreased by 14.4% in the Americas for the three months ended September 30, 2025.
• Gross profit as a percentage of net sales decreased to 74.8% for the nine months ended September 30, 2025, from 76.6% in the prior-year period, due to increased product costs and freight costs.
• Net realized and unrealized foreign currency loss of $2.6 million for the nine months ended September 30, 2025.

Risks

• Overall growth or lack of growth in the nutritional supplements industry.
• Changes in manufacturing costs.
• Shifts in the mix of packs and products.
• The future impact of any changes to global associate career and compensation plans or incentives or the regulations governing such plans and incentives.
• The ability to attract and retain independent associates and preferred customers.
• New regulatory changes that may affect operations, products, or compensation plans and incentives.
• The ability of outside suppliers and manufacturers to supply products in sufficient quantities and comply with product safety and quality standards or applicable law.
• The competitive nature of the business with respect to products and pricing.
• Publicity related to products or network marketing.
• The political, social, and economic climate of the countries in which the company operates.
• Changes in trade policy in the United States and other countries, including the imposition of tariffs and the resulting consequences, may adversely impact business, results of operations, and financial condition.
• Disruptions in the supply chain, delayed shipments, or increased operational complexity due to trade policies.
• Inability to fully recover cost increases through price adjustments due to competitive pressures, customer acceptance, and contractual limitations.
• Future access to capital markets may be adversely impacted if the company fails to maintain compliance with Nasdaq Marketplace Rules for continued listing.
• If reorganization plans are not successful, or if the company experiences further or unexpected disruption in its supply chain, and/or potential decreases in consumer demands, sales and overall liquidity could be negatively impacted.

Future Outlook

Management believes existing liquidity and cash flows from operations are adequate to fund normal expected future business operations for the next twelve months and for the long term. However, this is dependent on the ability to maintain or improve revenue compared to operational expenses. If reorganization plans are unsuccessful, or if supply chain disruptions and decreased consumer demand occur, sales and overall liquidity could be negatively impacted. The company may need to raise additional funds if capital resources become insufficient, which may not be available on favorable terms. Future access to capital markets could be adversely impacted if Nasdaq listing rules are not maintained.

Management Comments

• "We believe our existing liquidity and cash flows from operations are adequate to fund our normal expected future business operations for the next twelve months."
• "Our management has established a business reorganization plan focusing on revenue growth, margin improvement and cost control and reduction, including a plan to improve margin through a price increase, continued focus on supply chain costs, and certain compensation plan adjustments, as well as to reorganize certain functional operations and reduce our fixed selling and administrative overhead."
• "We continuously monitor our compliance with the Nasdaq continued listing rules."

Industry Context

The company operates in the nutritional supplement industry, utilizing a network marketing distribution channel. It also has a non-direct selling e-commerce model in mainland China. The filing mentions "overall growth or lack of growth in the nutritional supplements industry" as a risk factor, implying the company's performance is tied to broader industry trends. The decline in sales and associate recruitment could reflect a broader slowdown or increased competition within the industry.

Corporate Governance

Legal Proceedings

• As of September 30, 2025, the company had no open or pending litigation and no legal reserve was deemed necessary. The company believes existing claims can be resolved without material adverse effect on its consolidated financial position, results of operations, or cash flows.

Related Party Transactions

• Unsecured notes payable totaling $3.6 million were issued on April 23, 2024, to three related parties who are members of the Board of Directors and current stockholders: Jade Capital ($2.5 million, managing member Tyler Rameson is an independent director), J. Stanley Fredrick ($1.0 million, Chairman of the Board), and Kevin Robbins ($0.1 million, Board member).
• On September 9, 2025, loan extension agreements were entered into with these related parties, extending the maturity date of these notes from September 30, 2026, to March 31, 2027.

Stakeholder Impact

• Shareholders: Negative impact due to declining sales, net loss for the nine-month period, reduced cash, and potential future dilution if additional capital raises are needed. The extension of related-party debt could be viewed as a sign of financial strain.
• Employees: Potential impact from management's plan to "reorganize certain functional operations and reduce our fixed selling and administrative overhead" which could imply layoffs or restructuring.
• Associates/Distributors: Decreased recruitment and declining number of active associates and preferred customers suggest challenges in the network marketing model, potentially impacting their income opportunities. Changes to compensation plans are also mentioned.
• Creditors: The extension of notes payable maturity provides more time for repayment but also indicates the company's need for extended terms.
• Customers: Higher sales prices are mentioned as a strategy to improve gross profit, which could impact customer purchasing behavior.

Next Steps

• Implement a business reorganization plan focusing on revenue growth, margin improvement, and cost control/reduction.
• Improve margin through a price increase.
• Continue focus on supply chain costs.
• Adjust compensation plans.
• Reorganize certain functional operations and reduce fixed selling and administrative overhead.
• Continuously monitor compliance with Nasdaq continued listing rules.

Key Dates

Recommendation

The filing reveals a concerning trend of declining sales, a significant net loss for the nine-month period, and a substantial reduction in cash and working capital. While Q3 showed a net income rebound, the underlying operational challenges, including decreased associate recruitment and negative cash flow from operations, suggest a deteriorating business environment. The reliance on related-party debt, even with an extension, indicates liquidity pressures. The stated reorganization plan and price increases are attempts to stabilize, but the overall financial health and operational metrics point to continued headwinds and increased risk for investors.

Keywords

nutritional supplements, network marketing, direct selling, SEC filing, 10-Q, financial results, sales decline, net income, cash flow, liquidity, foreign exchange, associate fees, Nasdaq, MTEX, skin care, anti-aging, weight management